20.40
price up icon2.20%   0.44
after-market Dopo l'orario di chiusura: 20.23 -0.17 -0.83%
loading

Anaptysbio Inc Azioni (ANAB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
19.83%
22.26
27.77 30.02 10.97 7.179
Operating Expenses
12.43%
48.43
55.31 52.77 51.29 49.38
Benefits Costs and Expenses
9.25%
60.85
67.06 62.87 57.62 -
Costs And Expenses
9.25%
60.85
67.06 62.87 57.62 49.38
Operating Income/Loss
4.97%
-26.17
-27.54 -22.76 -40.32 -42.20
Nonoperating Income/Loss
5.75%
-12.42
-11.75 -10.09 -6.33 -1.735
Income/Loss From Continuing Operations Before Tax
1.77%
-38.59
-39.28 -32.85 -46.65 -43.94
Income Tax Expense/Benefit
11.36%
0.039
0.044 - 0.009 -
Income/Loss From Continuing Operations After Tax
1.78%
-38.63
-39.33 -32.85 -46.66 -43.94
Net Income/Loss
1.78%
-38.63
-39.33 -32.85 -46.66 -43.94
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.98%
28.81
30.64 28.89 27.36 26.80
Diluted Average Shares
5.98%
28.81
30.64 28.89 27.36 26.80
Basic Earnings Per Share
4.69%
-1.34
-1.28 -1.14 -1.71 -1.64
Diluted Earnings Per Share
4.69%
-1.34
-1.28 -1.14 -1.71 -1.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):